Medpace Holdings, Inc.

MEDP Healthcare Diagnostics & Research

Medpace Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 20.0% from fiscal 2024.

Revenue
+8.50%
EPS
+24.6%
Free cash flow
−16.6%

Quarter to September 2026, against a year earlier

653.87 18.89 +2.97%
Market cap
$17.8B
P/E
34.6×
Fwd P/E
35.8×
Dividend yield
—
F-score
8/9
Altman Z
8.04
Beneish M
−2.92
Dividend safety
n/a
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
35.87 25.44 33.22 27.37 43.01 34.20 30.13 25.20 37.14 90.29
Piotroski F-Score
8 7 9 8 7 7 7 9 5 7
Altman Z-Score
8.04 6.51 6.53 5.24 8.00 6.30 5.52 3.90 2.33 2.65
P/S ratio
6.40 4.88 4.98 4.62 6.83 5.36 3.50 2.67 3.33 3.04
P/FCF ratio
23.76 17.97 23.66 19.21 33.20 21.82 16.40 13.39 16.93 16.39
Altman Z″-Score (non-manufacturers)
0.20 1.89 0.15 (1.34) 3.21 2.68 2.62 1.66 0.80 1.83
Beneish M-Score
(2.92) (3.02) (2.79) (2.81) (2.62) (2.78) (2.69) (2.35) (2.76) (2.52)
P/Operating CF
84.10 53.94 60.03 49.35 110.09 47.02 52.97 47.70 50.63 44.10
P/B ratio
35.29 12.46 16.80 17.46 8.19 6.16 4.15 3.19 2.88 2.10
EV/Sales
6.25 4.61 4.91 4.67 6.49 5.13 3.43 2.81 3.83 3.41
EV/EBITDA
28.09 20.43 25.48 22.67 33.75 25.58 19.59 14.91 16.20 12.69
EV/FCF
23.19 17.00 23.33 19.43 31.55 20.91 16.04 14.08 19.52 18.37
Current Ratio
0.74 0.93 0.64 0.42 1.24 1.08 0.92 0.69 0.67 0.79
Net Debt/EBITDA
(0.88) (1.41) (0.68) 0.07 (2.03) (1.41) (0.80) 0.62 2.15 1.37
Debt/Equity
0.00 0.00 0.00 0.13 0.02 0.02 0.02 0.18 0.49 0.31
ROE
70.23% 58.42% 59.83% 36.64% 20.68% 18.92% 15.22% 13.34% 7.02% 2.62%
ROA
22.13% 21.52% 18.80% 16.29% 11.92% 11.44% 9.49% 7.60% 4.05% 1.37%
ROIC
0.00% 178.91% 67.15% 42.68% 24.45% 19.19% 13.14% 9.39% 5.59% 4.29%
Return on Tangible Assets
(202.23%) 837.39% (134.22%) (68.22%) 80.16% 122.24% 469.86% (273.45%) (279.52%) 158.88%
Average Days of Receivables
58.00 51.30 57.75 63.35 59.57 63.45 65.99 69.13 69.53 69.06
Earnings Yield
2.79% 3.93% 3.01% 3.65% 2.32% 2.92% 3.32% 3.97% 2.69% 1.11%
Free Cash Flow Yield
4.21% 5.56% 4.23% 5.21% 3.01% 4.58% 6.10% 7.47% 5.91% 6.10%
Free Cash Flow per Share
23.64 18.49 12.91 10.84 6.55 6.38 5.13 3.95 2.18 2.19
Book value per Share
15.91 26.67 18.19 11.93 26.57 22.61 20.24 16.59 12.89 17.11
Free Cash Flow
681.87 572.27 396.73 351.17 235.06 227.34 183.96 140.56 85.09 78.20
EV/EBIT
29.56 21.77 27.47 24.48 37.34 28.46 23.19 19.58 25.78 27.37
Other line items

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026